
Oxbridge Re Holdings Limited (NASDAQ:OXBR – Free Report) – Investment analysts at Maxim Group reduced their Q3 2026 earnings estimates for shares of Oxbridge Re in a research report issued to clients and investors on Monday, August 17th. Maxim Group analyst A. Klee now expects that the insurance provider will post earnings of ($0.06) per share for the quarter, down from their prior estimate of ($0.05). Maxim Group currently has a “Buy” rating and a $3.00 target price on the stock. The consensus estimate for Oxbridge Re’s current full-year earnings is ($0.04) per share. Maxim Group also issued estimates for Oxbridge Re’s Q4 2026 earnings at ($0.04) EPS, FY2026 earnings at ($0.08) EPS, Q1 2027 earnings at ($0.07) EPS, Q3 2027 earnings at ($0.07) EPS, Q4 2027 earnings at ($0.07) EPS and FY2027 earnings at ($0.18) EPS.
Other research analysts have also issued reports about the company. Weiss Ratings upgraded Oxbridge Re from a “sell (d-)” rating to a “sell (d+)” rating in a research report on Friday. Zacks Research raised Oxbridge Re to a “hold” rating in a research note on Wednesday, June 17th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Oxbridge Re has an average rating of “Hold” and a consensus target price of $3.00.
Oxbridge Re Stock Down 1.5%
Shares of NASDAQ OXBR opened at $1.35 on Wednesday. The firm has a market cap of $10.94 million, a price-to-earnings ratio of 67.53 and a beta of 1.94. Oxbridge Re has a 52-week low of $0.66 and a 52-week high of $2.86. The business’s 50 day moving average is $1.30 and its two-hundred day moving average is $1.07.
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last posted its quarterly earnings data on Thursday, August 13th. The insurance provider reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.01). Oxbridge Re had a return on equity of 2.14% and a net margin of 4.71%.The company had revenue of $0.94 million for the quarter, compared to analysts’ expectations of $1.10 million.
Institutional Trading of Oxbridge Re
A number of large investors have recently made changes to their positions in OXBR. Virtu Financial LLC purchased a new stake in Oxbridge Re during the 3rd quarter worth about $32,000. International Assets Investment Management LLC purchased a new position in shares of Oxbridge Re in the 4th quarter valued at about $39,000. Finally, J.W. Cole Advisors Inc. increased its holdings in shares of Oxbridge Re by 106.1% in the 4th quarter. J.W. Cole Advisors Inc. now owns 68,000 shares of the insurance provider’s stock valued at $90,000 after acquiring an additional 35,000 shares during the last quarter. 5.64% of the stock is currently owned by hedge funds and other institutional investors.
Oxbridge Re Company Profile
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Featured Articles
- Five stocks we like better than Oxbridge Re
- Speed Sells: Cerebras Cracks the Silicon Ceiling
- Amid Legal Risks, This Company Is Still Rated a Buy
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
